XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert S. who wrote (6671)	7/13/1998 10:28:00 PM
From: aknahow	Read Replies (1) of 17367

Since BPI has been around a long time, in humans, I am also one of those that believe resistance will not be a problem. The kill rate seems related to the dosage. For Abdominal infection a 100% Cure or improvement was see with a dose of 4.0 mg//kg compared to 75% when the dose was 0.5. Again on the macro concept of resistance I believe it would apply to almost any non host derived drug. And indeed it might also in some way, someday apply to host derived drugs also. So does that mean one discards investment in biotech stocks? I think RobertK and many others can give you much better answers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next